Treatment responses with once-weekly teriparatide therapy for osteoporosis

被引：0
|
作者：
M. Shiraki
S. Ueda
T. Sugimoto
T. Kuroda
T. Nakamura
机构：
[1] Research Institute and Practice for Involutional Diseases,Department of Internal Medicine
[2] Asahi Kasei Pharma Corporation,Medical Affairs Department
[3] Shimane University Faculty of Medicine,Internal Medicine 1
[4] National Center for Global Health and Medicine,undefined
来源：
Osteoporosis International | 2016年 / 27卷
关键词：
Bone mineral density; Incident fracture; Teriparatide; Treatment success;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3057 / 3062
页数：5
相关论文
共 50 条
  • [1] Treatment responses with once-weekly teriparatide therapy for osteoporosis
    Shiraki, M.
    Ueda, S.
    Sugimoto, T.
    Kuroda, T.
    Nakamura, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 (10) : 3057 - 3062
  • [2] Once-weekly treatment for osteoporosis
    Stone, M
    [J]. HOSPITAL MEDICINE, 2002, 63 (04): : 230 - 232
  • [3] The impact of switching once-weekly teriparatide to denosumab in osteoporosis patients
    Miyagi, Masayuki
    Fujimaki, Hisako
    Naruse, Kouji
    Suto, Kaori
    Inoue, Gen
    Nakazawa, Toshiyuki
    Imura, Takayuki
    Saito, Wataru
    Uchida, Kentaro
    Shirasawa, Eiki
    Takahira, Naonobu
    Takaso, Masashi
    [J]. JOURNAL OF ORTHOPAEDIC SCIENCE, 2019, 24 (01) : 153 - 158
  • [4] Once-weekly teriparatide reduces serum sclerostin levels in osteoporosis patients
    Ikeda, Terumasa
    Akagi, Masao
    Kaji, Hiroshi
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 362 - 362
  • [5] The impact of switching once-weekly teriparatide to denosumab in severe osteoporosis patients
    Miyagi, Masayuki
    Murata, Kosuke
    Koyama, Tomohisa
    Fujimaki, Hisako
    Naruse, Koji
    Inoue, Gen
    Takaso, Masashi
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 175 - 175
  • [6] Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    T. Kawada
    [J]. Osteoporosis International, 2014, 25 : 2321 - 2321
  • [7] Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
    Kawada, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (09) : 2321 - 2321
  • [8] Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
    Sebba, AI
    Bonnick, SL
    Kagan, R
    Thompson, DE
    Skalky, CS
    Chen, EL
    de Papp, AE
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) : 2031 - 2041
  • [9] ONCE-WEEKLY TERIPARATIDE IS EFFECTIVE FOR GLUCOCORTICOID-INDUCED OSTEOPOROSIS PATIENTS WITH COLLAGEN DISEASES
    Seno, T.
    Yamamoto, A.
    Kukida, Y.
    Tominaga, A.
    Kida, T.
    Nakabayashi, A.
    Fujioka, K.
    Nagahara, H.
    Murakami, K.
    Fujii, W.
    Oda, R.
    Kubo, T.
    Kohno, M.
    Kawahito, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1204 - 1205
  • [10] New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
    Tanaka, Sakae
    Adachi, Taiji
    Kuroda, Tatsuhiko
    Nakamura, Toshitaka
    Shiraki, Masataka
    Sugimoto, Toshitsugu
    Takeuchi, Yasuhiro
    Saito, Mitsuru
    Bilezikian, John P.
    [J]. BONE RESEARCH, 2014, 2
12345